Our patient investment philosophy
A Patient View
"Time is the friend of the wonderful company, the enemy of the mediocre."- Warren Buffett
- Compels us to wait for the perfect pitch - differentiated companies with strong cash flows, low debt, high quality products or services, significant barriers to entry and low reinvestment requirements.
- Allows us to take a long-term view and look past short-term noise with a 3-5 year time horizon in mind.
A Focused Approach
"Invest within your circle of competence." - Warren Buffett- Augments our conviction, especially during crunch time when it matters most.
- Leads us to isolate key issues of importance to a company in the midst of market noise.
- Results in our portfolio concentration in a limited number of names and industries.
A Team of Independent Thinkers
"If you buy the same stocks as everyone else, you get the same results."- Sir John Templeton
- Encourages us to buy out of favor, misunderstood and ignored stocks.
- Leads us to perform our own original, proprietary research.
- Persuades us to be benchmark agnostic with very different industry weightings.
We believe ethical business practices make good investment sense.
We do not invest in corporations whose primary source of revenue is derived from:
- the production or sale of tobacco products or
- the manufacture of handguns.
Additionally, we consider a company’s environmental record which includes reviewing research from outside vendors that provide such services, and we encourage portfolio companies to have proactive diversity practices.
For more information, read The Responsibility Factor.
Investor Class: 06/30/2005
Institutional Class: 12/30/2011
Investor Class: ARFFX
Institutional Class: AFOYX
$47.9 million as of 3/31/2013
[video] Charlie Bobrinskoy discusses Ariel’s unique approach to finding high-quality companies with fortress-like balance sheets.
[video] Tim Fidler describes our bottom-up approach to portfolio construction.
Ariel Focus Fund Performance as of April 30, 2013
| Inception date: June 30, 2005 | Annualized | ||||||
| One Month | Three Months | Year To Date | One Year | Three Years | Five Years | Since Inception | |
|---|---|---|---|---|---|---|---|
| Ariel Focus Fund | 1.70% | 7.46% | 15.91% | 16.35% | 8.58% | 3.38% | 3.95% |
| Russell 1000® Value Index | 1.51% | 7.05% | 14.01% | 21.80% | 12.35% | 4.17% | 5.38% |
| S&P 500® Index | 1.93% | 7.18% | 12.74% | 16.89% | 12.80% | 5.21% | 6.03% |
Ariel Focus Fund Performance as of March 31, 2013
| Inception date: June 30, 2005 | Annualized | ||||||
| One Month | Three Months | Year To Date | One Year | Three Years | Five Years | Since Inception | |
|---|---|---|---|---|---|---|---|
| Ariel Focus Fund | 4.23% | 13.97% | 13.97% | 11.13% | 8.26% | 4.06% | 3.77% |
| Russell 1000® Value Index | 3.96% | 12.31% | 12.31% | 18.77% | 12.74% | 4.85% | 5.23% |
| S&P 500® Index | 3.75% | 10.61% | 10.61% | 13.96% | 12.67% | 5.81% | 5.83% |
> Compare Performance for all our Funds
> View Historical Quarter-by-Quarter Performance
Gross Expense Ratio as of the fiscal year ended 9/30/12: 1.58%*
*Ariel Investments, LLC, the Adviser, is contractually obligated to waive fees or reimburse expenses in order to limit Ariel Focus Fund’s total annual operating expenses to 1.25% of net assets for the Investor Class through the end of the fiscal year ending September 30, 2014. No termination of this agreement by either the Board of Trustees or the Adviser may be effective until, at the earliest, October 1, 2014.
Ariel Focus Fund is a non-diversified fund and therefore may be subject to greater volatility than a more diversified investment. Investing in equity stocks is risky and subject to the volatility of the markets. Investing in small cap and mid-cap stocks is more risky and more volatile than investing in large cap stocks. Performance data quoted represents past performance. Past performance does not guarantee future results. All performance assumes the reinvestment of dividends and capital gains. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance data quoted.
The Russell 1000® Value Index measures the performance of the large-cap value segment of the U.S. equity universe. It includes those Russell 1000 companies with lower price-to-book ratios and lower expected growth values. Russell® is a trademark of Russell Investment Group, which is the source and owner of the Russell Indexes’ trademarks, service marks and copyrights. The S&P 500® Index is the most widely accepted barometer of the market. It includes 500 blue chip, large cap stocks, which together represent about 75% of the total U.S. equities market.
Investors should consider carefully the investment objectives, risks, and charges and expenses before investing. For a current summary prospectus or full prospectus which contains this and other information about the funds offered by Ariel Investment Trust, call us at 800-292-7435 or click here. Please read the summary prospectus or full prospectus carefully before investing. Distributed by Ariel Distributors, LLC, a wholly-owned subsidiary of Ariel Investments, LLC.
Schedule of Holdings as of March 31, 2013
| Shares | Security Description | CUSIP | Ticker | Current Value ($) | % of Net Assets |
|
|---|---|---|---|---|---|---|
| 98,900 | Microsoft Corp. | 594918104 | MSFT | 2,829,529 | 5.9 | |
| 55,300 | Walgreen Co. | 931422109 | WAG | 2,636,704 | 5.5 | |
| 30,800 | Johnson & Johnson | 478160104 | JNJ | 2,511,124 | 5.2 | |
| 150,200 | Western Union Co. | 959802109 | WU | 2,259,008 | 4.7 | |
| 32,400 | Target Corp. | 87612E106 | TGT | 2,217,780 | 4.6 | |
| 22,400 | Lockheed Martin Corp. | 539830109 | LMT | 2,162,048 | 4.5 | |
| 35,700 | Omnicom Group Inc. | 681919106 | OMC | 2,102,730 | 4.4 | |
| 26,700 | National Oilwell Varco | 637071101 | NOV | 1,889,025 | 3.9 | |
| 20,500 | Exxon Mobil Corp. | 30231G102 | XOM | 1,847,255 | 3.9 | |
| 38,700 | JPMorgan Chase & Co. | 46625H100 | JPM | 1,836,702 | 3.8 | |
| 12,000 | Goldman, Sachs & Co. | 38141G104 | GS | 1,765,800 | 3.7 | |
| 1,735,672 | Fixed Income Clearing Corporation | 85748R009 | 1,735,672 | 3.6 | ||
| 78,450 | Morgan Stanley | 617446448 | MS | 1,724,331 | 3.6 | |
| 85,700 | KKR & Co. L.P. | 48248M102 | KKR | 1,655,724 | 3.5 | |
| 21,400 | Zimmer Holdings, Inc. | 98956P102 | ZMH | 1,609,708 | 3.4 | |
| 7,500 | International Business Machines Corp. | 459200101 | IBM | 1,599,750 | 3.3 | |
| 18,900 | Snap-on Inc. | 833034101 | SNA | 1,563,030 | 3.3 | |
| 72,200 | Chesapeake Energy Corp. | 165167107 | CHK | 1,473,602 | 3.1 | |
| 73,400 | Blackstone Group L.P. | 09253U108 | BX | 1,451,852 | 3.0 | |
| 17,500 | Stanley Black & Decker, Inc. | 854502101 | SWK | 1,416,975 | 3.0 | |
| 24,600 | Northern Trust Corp. | 665859104 | NTRS | 1,342,176 | 2.8 | |
| 38,800 | Hospira, Inc. | 441060100 | HSP | 1,273,804 | 2.7 | |
| 18,500 | Illinois Tool Works Inc. | 452308109 | ITW | 1,127,390 | 2.4 | |
| 19,500 | Walt Disney Co. | 254687106 | DIS | 1,107,600 | 2.3 | |
| 37,500 | Bank of New York Mellon Corp. | 064058100 | BK | 1,049,625 | 2.2 | |
| 29,700 | DeVry Inc. | 251893103 | DV | 942,975 | 2.0 | |
| 12,800 | Baxter Intl Inc. | 071813109 | BAX | 929,792 | 1.9 | |
| 12,100 | Accenture plc | G1151C101 | ACN | 919,237 | 1.9 | |
| 49,600 | Apollo Group, Inc. | 037604105 | APOL | 862,544 | 1.8 | |
| Cash, Other Assets and Liabilities | 64,958 | 0.1 | ||||
| Grand Total | $47,908,450 | 100.0% | ||||
Sector Weightings (%) as of March 31, 2013
| Ariel Focus Fund | Russell 1000 Value | S&P 500 | |
|---|---|---|---|
| Financial Services | 28.38 | 27.85 | 17.19 |
| Consumer Discretionary | 19.08 | 8.69 | 13.61 |
| Health Care | 13.72 | 11.77 | 12.37 |
| Producer Durables | 12.20 | 9.07 | 10.57 |
| Energy | 11.30 | 15.73 | 10.93 |
| Technology | 9.60 | 6.26 | 15.65 |
| Consumer Staples | 5.72 | 7.05 | 9.56 |
| Utilities | 0.00 | 9.88 | 6.33 |
| Materials and Processing | 0.00 | 3.69 | 3.78 |
> View Historical Sector Diversification
Represents percentage of total equity holdings in the portfolio
Portfolio Characteristics as of March 31, 2013
| Market Capitalization | Ariel Focus Fund | Russell 1000 Value | S&P 500 | |
|---|---|---|---|---|
| Market Capitalization | (In billions) | |||
| Large Capitalization | 64.31 & Above | 29.3 | 39.5 | 48.1 |
| Medium/Large Capitalization | 18.65 -- 64.31 | 31.8 | 29.3 | 31.4 |
| Medium Capitalization | 6.39 -- 18.65 | 25.3 | 19.0 | 18.1 |
| Medium/Small Capitalization | 2.39 -- 6.39 | 9.7 | 11.0 | 2.4 |
| Small Capitalization | 2.39 & Below | 3.9 | 1.3 | 0.0 |
| Dollar-Weighted Average (BIL)* | $33.88 | $41.91 | $58.72 | |
| Valuation Metrics | ||||
| Forward Price/Earnings | 12.0 | 13.0 | 14.0 | |
| Trailing Price/Earnings | 15.3 | 15.9 | 17.0 | |
| Discount to Private Market Value | -18.0 | n/a | n/a | |
| Fundamentals | ||||
| 5 Yr. Estimated Earnings Growth ** | 9.0 | 8.7 | 10.8 | |
| Interest Coverage Ratio | 6.9 | 5.4 | 7.2 | |
| Portfolio Construction | ||||
| Number of Holdings | 28 | 695 | 500 | |
| Turnover | 34.6 | n/a | n/a | |
> View Historical Portfolio Characteristics
Market Capitalization data, Valuation Metrics, Fundamentals and Number of Holdings are obtained from BNY Mellon. Portfolio Turnover is generated internally through Fiserv APL.
*Market Capitalization is a dollar-weighted average natural log. Using the natural log of each stock’s market capitalization reduces the weight given to the largest companies in a simple averaging process.
**This measure is not a forecast of the fund’s performance.
The Russell 1000® Value Index measures the performance of the large-cap value segment of the U.S. equity universe. It includes those Russell 1000 companies with lower price-to-book ratios and lower expected growth values. Russell® is a trademark of Russell Investment Group, which is the source and owner of the Russell Indexes’ trademarks, service marks and copyrights. The S&P 500® Index is the most widely accepted barometer of the market. It includes 500 blue chip, large cap stocks, which together represent about 75% of the total U.S. equities market.
The four-part investment process drives us to take a long-term view, focusing on what matters most through independent thought and research.
The Idea: We read extensively, monitor computer screens, meet with industry experts, and stay abreast of former holdings.
The Science: We seek to purchase companies that trade at a 40% discount to the PMV we have calculated, sell for 13x or less forward cash earnings estimates, or both.
The Art: We surround companies to paint a long-term picture and identify what others are missing. The chief tool is our extensive independent verification network — the many experts we know well. We use strategic questioning of company management and outside experts to identify the key issues affecting an industry or company.
The Decision: We generally purchase only a few companies each year so we weigh our options carefully. Typically, key information is captured in a research report. The co-portfolio managers vet the idea in a vigorous discussion. After this step, the co-portfolio managers make the final purchase decision.


